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Colldén H, Landin A, Wallenius V, Elebring E, Fändriks L,
Nilsson ME, Ryberg H, Poutanen M, Sjögren K, Vandenput L,
Ohlsson C. The gut microbiota is a major regulator of androgen
metabolism in intestinal contents. Am J Physiol Endocrinol Metab
317: E1182–E1192, 2019. First published November 5, 2019; doi:
10.1152/ajpendo.00338.2019.—Androgens exert important effects
both in androgen-responsive tissues and in the intestinal tract. To
determine the impact of the gut microbiota (GM) on intestinal andro-
gen metabolism, we measured unconjugated (free) and glucuronidated
androgen levels in intestinal contents from the small intestine, with a
low bacterial density, and from cecum and colon, with a high bacterial
density. Using a specific, sensitive gas chromatography-tandem mass
spectrometry method, we detected high levels of glucuronidated
testosterone (T) and dihydrotestosterone (DHT) in small intestinal
content of mice of both sexes, whereas in the distal intestine we
observed remarkably high levels of free DHT, exceeding serum levels
by 20-fold. Similarly, in young adult men high levels of unconju-
gated DHT, 70-fold higher than in serum, were detected in feces. In
contrast to mice with a normal GM composition, germ-free mice had
high levels of glucuronidated T and DHT, but very low free DHT
levels, in the distal intestine. These findings demonstrate that the GM
is involved in intestinal metabolism and deglucuronidation of DHT
and T, resulting in extremely high free levels of the most potent
androgen, DHT, in the colonic content of young and healthy mice and
men.
dihydrotestosterone; glucuronidation; gut bacteria; intracrinology; tes-
tosterone
INTRODUCTION
Testis-derived testosterone (T) is the most abundant andro-
gen in the systemic circulation in males, whereas the ovaries
are the most important source of androgens in females of
reproductive age. Androgen production in the gonads is regu-
lated by gonadotropins luteinizing hormone (LH) and follicle-
stimulating hormone (FSH), which in turn are regulated by
negative feedback of the steroids produced (4, 8). In humans,
the adrenal-derived androgen precursor dehydroepiandros-
terone (DHEA) also contributes to androgen synthesis (9).
Although DHEA is not produced in mice, the mouse adrenal
gland may still also contribute to androgen synthesis via
production of the androgen precursor androstenedione (A-
dione) (12, 28, 34), which can be converted to T by 17-
hydroxysteroid dehydrogenases (Fig. 1) (8). In target tissues
and in the liver, T can be further metabolized by a number of
different phase I reactions (e.g., reduction) and phase II reac-
tions (e.g., glucuronidation) (Fig. 1) (41). In certain male
reproductive tissues, such as prostate and seminal vesicles, T is
converted into the more potent androgen dihydrotestosterone
(DHT) by 5-reductase type 2 enzyme (SRD5a2), whereas in
the liver mainly 5-reductase type 1 enzyme (SRD5a1) con-
verts T into DHT (29). Another homologous enzyme, SRD5a3,
has been identified (47), but whether it has the capacity to
convert T to DHT is still unclear (13, 14). Both T and DHT can
be conjugated, mainly in the liver but also in other tissues, by
glucuronidation, which increases the water solubility of the
compounds. The glucuronidated androgens are excreted in
urine or via bile to the small intestine (6, 8).
The gut microbiota (GM) consists of trillions of bacteria,
virus, and fungi that have coevolved with its host and has been
described as a virtual endocrine organ that can produce and
excrete a number of substances into its host’s bloodstream,
thereby affecting host physiology (15). The number of bacteria
and the metabolic capacity of the GM are higher in the cecum
and colon compared with the small intestine (10). The compo-
sition of the GM also changes along the gastrointestinal (GI)
tract (24). Certain strains of bacteria have been shown in vitro
to have the ability to metabolize androgens, for example,
converting T into DHT (45). The physiological relevance of
the GM in androgen metabolism and in levels of glucuroni-
dated and free androgens in different regions in the intestine is
mostly unknown. In a recent study, a link between the GM and
androgen concentrations in mice was observed, with female
mice having received male intestinal contents showing in-
creased serum T levels. The local androgen levels in intestinal
contents were, however, not analyzed in the study (33).
Germ-free (GF) mice have been successfully used to eval-
uate the role of the GM in many physiological and pathophys-
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iological conditions such as obesity, osteoporosis, and neu-
roendocrine disorders (32, 43). They are bred in a sterile
environment in isolators and are not colonized by bacteria,
fungi, or viruses. To the best of our knowledge, androgen
levels in intestinal contents and extraintestinal tissues of GF
mice have not previously been thoroughly assessed.
We hypothesized that the GM, with low abundance in the
small intestine and high abundance in the distal intestine, might
modulate androgen metabolism and thereby affect local andro-
gen levels in a site-specific manner along the GI tract. To
enable quantification of androgens in intestinal contents, we
modified and validated our specific gas chromatography-tan-
dem mass spectrometry (GC-MS/MS) method previously de-
veloped for serum sex steroid analyses (37). We observed
major GM-dependent differences in levels of glucuronidated
and free androgens in the intestinal contents from the small
intestine and the more distal regions of the intestine. We also
observed GM-dependent changes in androgen action in ex-
traintestinal tissues. Overall, these findings identify the GM as
a major regulator of local androgen action in the intestine as
well as in other peripheral tissues.
MATERIALS AND METHODS
Animals
Wild-type C57BL/6 mice (n  7 per sex) were purchased from
Charles River (Wilmington, MA) and housed in the animal facility at
the University of Gothenburg with controlled temperature (22°C) and
light cycle (12 h light and 12 h dark). The mice were fed a soy-free
pellet diet (Teklad Global 16% diet) and had free access to water.
Conventionally raised murine pathogen-free (CONV-R) and GF wild-
type C57BL/6 mice (n  10 per group and sex) were housed in
Taconic facilities (Germantown, NY) and were fed autoclaved NIH-
31M diet. Sterility of GF animals was routinely confirmed by aerobic
and anaerobic fecal cultures and 16S bacterial RNA screening via
PCR of fecal samples. At 8 wk of age, animals were anesthetized and
blood was collected from the axillary vein. The animals were subse-
quently euthanized by cervical dislocation, and tissues and intestinal
wall and contents were immediately collected, weighed, and snap
frozen in liquid nitrogen. Blood was coagulated at room temperature
for at least 30 min and centrifuged for 5 min, and the serum was
collected and snap frozen. All animal experiments were conducted in
accordance with all relevant legislation, and the experiments con-
ducted in-house were approved by the ethics committee of the Uni-
versity of Gothenburg (ethical approval no 194-2015).
Clinical Samples
Serum and feces samples were obtained from eight healthy men
aged 23–31 yr [body mass index 24.0 0.6 kg/m2 (mean  SE)]
participating in a study on lipid metabolism in the intestine. The study
was approved by the regional ethical review board in Gothenburg
(ethical approval no 807-11), and written informed consent was
obtained from all study participants.
Androgen Analysis
Sample preparation. Frozen tissues, serum, and intestinal contents
were thawed on ice. A sample of 2–100 mg (depending on sample
type and size) was weighed and placed in a 2-mL screw-top Eppen-
dorf tube with 450 L of phosphate-buffered saline. The samples
were homogenized by shaking with a 5-mm steel bead in a Tissue-
lyzer II for 5 min. Serum samples were measured volumetrically by
pipetting and adjusted to a volume of 450 L with deionized water.
Deglucuronidation. We have previously developed a GC-MS/MS
assay that measures unconjugated androgens (37). To be able to assess
glucuronidated forms of these steroids, we compared free levels of
each hormone with and without enzymatic deglucuronidation. All
intestinal contents were thus divided into two aliquots before homog-
enization, and one of the aliquots from each sample was deglucuroni-
dated by adding 50 L of -glucuronidase (from Escherichia coli
K12 in 50% glycerol solution; Roche, Basel, Switzerland), followed
by brief vortexing and incubation at 37°C with agitation for 1 h.
Samples were then frozen at –80°C until steroid extraction and
analysis. The difference between total and free levels was calculated
at each site and labeled glucuronidated.
Androgen extraction and analysis. Steroids were extracted, deriva-
tized, and measured as described previously with modifications as
outlined below (37). Briefly, after addition of isotope-labeled stan-
dards, steroids were extracted by liquid-liquid extraction with 1-chlo-
robutane, followed by solid-phase extraction with Silica SPE columns
(Hypersep Si 500 mg; Thermo Scientific, Waltham, MA) that were
washed with ethyl acetate-pentane-heptane [10:45:45 (vol:vol:vol)].
For intestinal content and liver samples three washing steps were used
instead of the regular two. Next, the analytes were eluted to isooctane
and the organic solvent evaporated. Finally, derivatization was per-
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Fig. 1. Schematic representation of androgen metabolism. The androgen
precursor androstenedione (A-dione) can be reversibly metabolized to testos-
terone (T) by 17-hydroxysteroid dehydrogenase enzymes (17-HSD). T can
then be reduced by 5-reductase enzymes to the more potent androgen
dihydrotestosterone (DHT). Both T and DHT can be glucuronidated (-G) in the
liver by uridine diphosphate-glucuronosyltransferase (UGT) 2B enzymes to
make them more water soluble and facilitate excretion. Glucuronidation is
reversible.
Table 1. Precision of assay in intestinal contents
DHT Testosterone Androstenedione
QC-low 12.2% (20) 12.2% (40) 1.0% (7.5)
QC-high 4.9% (200) 0.2% (1,000) 3.1% (375)
Validation of the gas chromatography-tandem mass spectrometry method.
Precision is calculated as the coefficient of variation (CV) for the 3 androgens
in spiked intestinal contents. Values within parentheses are the concentration
for the quality control (QC; in pg/g). Calculated as CV of 4 samples. DHT,
dihydrotestosterone; QC-low, QC sample with low concentration; QC-high,
QC sample with high concentration.
Table 2. Accuracy of assay in intestinal contents
Spiked, pg/g Baseline, pg/g Accuracy, %
DHT
Low 20 0 114
High 200 0 100
Testosterone
Low 40 0 109
High 100 0 107
Androstenedione
Low 7.5 0 85
High 37.5 0 95
Values are accuracy of the gas chromatography-tandem mass spectrometry
method used, determined by spiking intestinal content samples with isotope-
labeled androgens at low and high concentrations. Calculated as (measured
androgen–baseline androgen)/spiked androgen  100, as mean of 4 samples.
DHT, dihydrotestosterone.
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Table 3. Overview of comparisons made in the experiments
Figure Strain, Subjects n Analyses Comparison Statistical Test
2, 3 C57BL/6 wild-type mice,
CONV-R
7 Androgens Cecum and colon vs.
small intestine
Wilcoxon pairwise signed rank
4 C57BL/6 wild-type mice,
CONV-R
10 Androgens Different tissues No statistical test, descriptive
5, 6 C57BL/6 wild-type mice, GF
and CONV-R
10 Androgens in intestinal
contents
GF vs. CONV-R Mann–Whitney U test
7D, 8, 9;
Table 4
C57BL/6 wild-type mice, GF
and CONV-R
8–10 Androgens, gonadotropins,
tissue weights
GF vs, CONV-R Student’s unpaired t test, 2 tailed
10 Young adult men 8 Androgens Serum vs. feces Student’s paired t test, 2 tailed
n  no. per group. CONV-R, conventionally raised; GF, germ free.
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Fig. 2. Comparison of glucuronidated and unconjugated androgens in contents of small and distal intestine of mice with normal gut microbiota.
Unconjugated (free) and glucuronidated (gluc) androgen levels were measured by gas chromatography-tandem mass spectrometry in different parts of the
intestine, serum, and liver of 8-wk-old C57BL/6 mice. A–D: dihydrotestosterone (DHT) in males (A and B) and females (C and D). E–H: testosterone
(T) in males (E and F) and females (G and H). I–L: the androgen precursor androstenedione (A-dione) in males (I and J) and females (K and L). Values
are shown as means  SE; n  7 mice. ND, not detectable; dotted horizontal line denotes the corresponding serum free level. In serum the unit of
measurement is picograms per milliliter. To compare cecum and colon with small intestine, Wilcoxon matched-pairs signed-rank test was employed. *P 	
0.05 vs. small intestine.
E1184 GUT MICROBIOTA AND ANDROGEN METABOLISM
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00338.2019 • www.ajpendo.org
Downloaded from www.physiology.org/journal/ajpendo at Australian Catholic Univ (203.010.044.061) on January 19, 2020.
formed in two steps: oximation with pentafluorobenzylhydroxylamine
hydrochloride followed by esterification with pentafluorobenzoyl chlo-
ride. DHT, T, and A-dione were separated on a gas chromatograph and
detected simultaneously with electron capture negative chemical ioniza-
tion by an Agilent 7000 triple quadrupole mass spectrometer (Agilent,
Santa Clara, CA) operating in multiple reaction monitoring mode with
ammonia as reagent gas. All peaks were automatically integrated with the
MassHunter quantitative analysis workstation software from Agilent. The
measured concentration was corrected for the amount of input material
(wet mass of intestinal contents and tissues or volume of serum). The
assay was validated by spiking samples of intestinal content with differ-
ent concentrations of isotope-labeled DHT, T, and A-dione, and the
accuracy (%) was calculated as (measured androgen 
 baseline andro-
gen)/spiked androgen  100. The lower limit of quantification (LLOQ)
was defined as the lowest concentration with a coefficient of variation
(CV) 	 20% and accuracy 80–120%. Precision and accuracy were
determined as the mean of four samples (Tables 1 and 2). Serum LH and
FSH were measured by time-resolved immunofluorometric assays as
previously described (25, 48).
Values below the LLOQ were set to the LLOQ. To calculate the levels
of glucuronidated steroids, the free level (concentration without glucu-
ronidation) was subtracted from the total level (concentration after de-
glucuronidation). Since the calculation involved two separate sample
measurements, differences smaller than the assay’s CV% could not be
detected. Therefore, if the mean difference between total and free levels
was 	15% of the free value, or below the LLOQ, the glucuronidated
levels were denoted not detectable. To make intraintestinal and tissue
steroid concentrations comparable to those in the serum, 1 g of tissue or
intestinal contents was considered equivalent to 1 mL of serum. Andro-
gen levels in the small intestinal content were analyzed from three
separate locations (proximal jejunum, midjejunum, and ileum). The
androgen levels were very similar at these locations, and therefore the
mean for each androgen at all small intestinal locations with at least 8 mg
sample size was calculated for each mouse and referred to as the
androgen level in the small intestinal content.
Real-Time Quantitative PCR
RNA was isolated from muscle (quadriceps), seminal vesicle, liver,
and intestinal wall from four parts of the small intestine (duodenum,
proximal jejunum, midjejunum, and ileum), cecum, and colon with the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions. cDNA was synthesized with the High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City,
CA). Amplifications were performed with the StepOnePlus Real-
Time PCR System (Applied Biosystems) and TaqMan probes
(Applied Biosystems), labeled with the reporter fluorescent dye
FAM (Srd5a1: Mm_00614213_m1, Srd5a2: Mm00446421_m1,
Srd5a3: Mm_04243702_m1). As an internal standard, predesigned
primers and probe labeled with the reporter fluorescent dye VIC, specific
for 18S ribosomal RNA, were included in the reactions (4310893E;
Applied Biosystems). Relative expression was calculated by the CT
method (where CT is threshold cycle) with 18S as reference gene.
Statistical Analyses
We used Graph Pad Prism 8 (Graph Pad Software, San Diego, CA)
and Microsoft Excel 16 (Microsoft Corp., Redmond, WA) for all
statistical analyses. Results are presented as means SE. For the
comparison of androgen levels in mouse intestinal contents we used
nonparametric tests since several measurements were below the
LLOQ, making the data not normally distributed. Wilcoxon matched-
pairs signed-rank test was used for cecum and colon compared with
the small intestine of the same animals, and Mann–Whitney U test
was used for the comparison between two groups (CONV-R vs. GF).
To compare gene expression, androgen levels in tissues, and serum
and tissue weights between the two mouse groups (CONV-R vs. GF),
Student’s two-tailed unpaired t test was used. For the comparison of
serum and fecal levels of androgens in humans, two-tailed paired
Student’s t test was used. (Table 3).
RESULTS
Comparison of Glucuronidated and Free Androgen Patterns
in Small Intestine, Distal Intestine, and Extraintestinal
Tissues
To assess the levels of different androgens and their glucu-
ronides in different regions within the GI tract, we first opti-
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Fig. 3. Comparison of unconjugated androgen fraction in small and distal
intestine of mice with normal gut microbiota: unconjugated fraction (% free)
of dihydrotestosterone (DHT; A and B), testosterone (T; C and D), and
androstenedione (A-dione; E and F) in parts of the intestine, serum, and liver
of 8-wk-old male and female C57BL/6 mice. Values are shown as
means  SE; n  7 mice. NA, not applicable. To compare cecum and colon
with small intestine, Wilcoxon matched-pairs signed-rank test was employed.
*P 	 0.05 vs. small intestine.
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mized and validated our established GC-MS/MS method (37)
for measurement of DHT, T, and A-dione in the intestinal
contents. The established assay for intestinal contents had a
LLOQ of 20, 40, and 7.5 pg/g for DHT, T, and A-dione,
respectively. The method presented excellent precision and
accuracy for analyses of androgens in intestinal content (Tables
1 and 2). All three examined androgens were present in
intestinal contents but with a site-specific pattern in young
adult mice.
In the small intestine the glucuronidated DHT levels were
high compared with colonic and cecal levels, whereas free
DHT levels were low in both male and female mice. In
contrast, in the cecum and colon glucuronidated DHT levels
were undetectable whereas remarkably high levels of free
DHT, exceeding the serum levels by 20-fold, were observed
in both male and female mice (Fig. 2, A–D). The glucuroni-
dated T levels were high in the small intestinal content com-
pared with the very low levels observed in cecal and colonic
contents. Free T levels were mainly unchanged between the
small intestinal content and the distal intestinal content in
cecum and colon in both male and female mice and were
similar to the serum levels in male mice and slightly higher
than the serum levels in female mice (Fig. 2, E–H). In the small
intestine nearly all DHT and T were present in the glucuroni-
dated form, whereas in distal regions of the intestine (cecum,
colon) nearly all DHT and a majority of T were present in the
free form (Fig. 3). The androgen precursor A-dione was pres-
ent throughout the intestine, with concentrations of the free
form higher than in serum in both males and females, whereas
it did not show extensive glucuronidation (Fig. 2, I–L, and Fig.
3E). In general, the intraintestinal patterns of free and glucu-
ronidated T and DHT were similar in females and males,
although the females, as expected, had lower levels of andro-
gens at all the regions measured (Fig. 2 and Fig. 3).
Although male cecal and colonic DHT levels were lower
than the levels in testis, they were substantially higher than
levels in the liver and thymus and ~25-fold higher than serum
DHT levels (Fig. 4A). In females, the levels of DHT observed
in the cecum and colon were similar to those measured in the
liver, whereas clearly lower levels were observed in the ovary
and thymus. No detectable DHT levels were observed in the
uterus or serum (Fig. 4B). Importantly, in female mice free
DHT levels in cecum and colon were higher than in most other
analyzed tissue (Fig. 4B).
Role of the Gut Microbiota for Glucuronidated and Free
Androgens in the Distal Intestine and in Extraintestinal
Tissues
The findings described above in mice with a normal GM
composition suggested that the microbiota present in the distal
intestine is responsible for the near-complete deconjugation of
DHT and T, causing a substantial difference in glucuronidated
and free androgen levels between the small intestine and the
cecum. This hypothesis was functionally tested by comparing
the levels of glucuronidated and free androgens in GF mice,
devoid of gut microbiota, with the corresponding levels in
CONV-R mice with a normal GM composition. In both males
and females, we observed considerably higher levels of glucu-
ronidated DHT but substantially lower levels of free DHT in
both cecal and colonic content of GF mice compared with
CONV-R mice (Fig. 5, A and B). In both sexes, GF mice also
had considerably higher levels of glucuronidated T in both
cecum and colon than those measured at corresponding sites in
CONV-R mice (Fig. 5, C and D). Unexpectedly, higher levels
of both free T and free A-dione were present in cecal content
of male GF compared with CONV-R mice (Fig. 5, C and E)
and free A-dione in cecal content of GF female mice (Fig. 5F).
However, free T levels were not different between GF and
CONV-R mice in the colon of male mice or in the cecum or
colon of female mice (Fig. 5, C and D). There were large
differences between GF and CONV-R mice regarding the free
fraction of T and DHT in cecum and colon for both males and
females. In GF mice the free fractions of total DHT and T were
	5%, whereas the free fractions in CONV-R mice were
between 60% and 100% (Fig. 6). No difference in the free
fraction of A-dione was found between the GF and CONV-R
mice (Fig. 6). These functional studies using GF mice estab-
lished that the GM is crucial for the deglucuronidation of DHT
and T in the distal intestine.
As levels of free DHT but not free T were increased in cecal
content compared with the small intestinal content (Fig. 2,
A–G), we hypothesized that the GM in cecum might regulate
the expression of 5-reductase enzymes (Srd5a1, Srd5a2,
Srd5a3) in the intestinal epithelium. Srd5a1 was expressed
throughout the GI tract at levels around 1/10th of those in the
liver used as a positive control (Fig. 7A). Also, Srd5a3 was
expressed in the intestinal wall throughout the intestine (Fig.
7C), whereas no substantial expression of Srd5a2 was ob-
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Fig. 4. Comparison of unconjugated dihy-
drotestosterone (DHT) levels in intestine and
extraintestinal tissues and serum of mice
with normal gut microbiota: DHT levels in
intestinal contents, serum, and tissues of
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served in the intestinal wall in any region of the GI tract
compared with the levels observed in seminal vesicles used as
a positive control (Fig. 7B). The expression of Srd5a1 was
unchanged whereas the expression of Srd5a3 was increased in
the cecal wall of GF mice versus CONV-R mice (Fig. 7D).
These data did not support the possibility that high 5-reduc-
tase expression could explain the very high levels of free DHT
in the distal intestine of CONV-R mice.
To address the potential effect of GM-regulated androgen
metabolism on extraintestinal tissues, we analyzed the andro-
gen content and androgen response in a set of extraintestinal
and androgen-responsive tissues in male GF and CONV-R
mice. DHT levels in serum did not differ between the groups,
but DHT levels in the liver and seminal vesicles were increased
in GF compared with CONV-R mice (Fig. 8A). T levels in
serum did not differ between the groups, and T levels in liver
were increased in GF compared with CONV-R mice (Fig. 8B),
whereas A-dione values did not differ between the groups in
serum or the evaluated extraintestinal tissues (Fig. 8C). GF
males had larger testes than CONV-R males (Table 4). Tissue
weights of seminal vesicles were increased in GF mice,
whereas the weight of thymus was decreased—both signs of
higher androgenic activity in this group (Table 4). To evaluate
whether the detected tissue-specific differences in extraintesti-
nal androgen levels and androgen activity in male mice were
due to altered feedback regulation of sex steroids, we analyzed
LH and FSH in serum from GF and CONV-R male mice. No
difference was seen in LH levels, but a significant increase of
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FSH levels was detected in GF mice compared with CONV-R
mice (Fig. 9). Thus glucuronidated DHT levels were substan-
tially higher whereas free DHT levels were lower in the distal
intestinal contents of GF compared with CONV-R mice; this
was associated with signs of increased androgenic activity in
some extraintestinal tissues of male GF compared with
CONV-R mice.
Comparison of Unconjugated Levels of DHT and T in Feces
and Serum of Young Adult Men
To translate the main finding of remarkably high unconju-
gated DHT levels in the distal intestinal content of mice to
human physiology, the levels of DHT and T were evaluated in
serum and feces from eight healthy young adult men. Similar
to our findings in mice, levels of unconjugated DHT, but not T,
in feces substantially exceeded the corresponding serum values
in these men (DHT: 74-fold higher; Fig. 10). Levels of glucu-
ronidated DHT and T in feces were not detectable with the
method used.
DISCUSSION
Androgens exert important physiological effects, and dis-
rupted androgen action has been associated with the patho-
physiology of a number of diseases in both men and women.
Although the physiological and pathophysiological roles of the
GM in metabolism have been extensively studied during recent
years, no previous study has evaluated the role of the GM in
androgen metabolism in the intestinal content. Using our op-
timized and validated GC-MS/MS method to analyze androgen
concentrations in intestinal contents, we demonstrated that
androgens are to a large extent present in the glucuronidated
form in the small intestine. Bacteria in the cecum are crucial
for the deglucuronidation of androgens, resulting in remark-
ably high free DHT levels (compared with serum levels) in the
distal intestinal content of both male and female mice. This
intriguing finding was also translated to humans, as similarly
high free DHT levels were observed in feces of healthy young
adult men.
In male and female mice with a normal GM composition we
observed that most of the DHT and T was present in the
glucuronidated form in the small intestine whereas most of the
DHT and T was present in the free form in the distal intestine
(cecum and colon). As the number of bacteria and the meta-
bolic activity of the GM in the distal intestine are substantially
higher than in the small intestine (24), we hypothesized that
bacteria present in cecum are responsible for the deglucuroni-
dation of DHT and T. We therefore investigated the role of the
GM in androgen metabolism in the distal intestine with the GF
mouse model completely lacking GM. GF mice had very high
levels of glucuronidated DHT and T in cecum, in the range of
what was found in the small intestine of CONV-R mice. This
novel finding demonstrates that the GM in cecum is crucial for
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deglucuronidation of both DHT and T. It is likely that bacterial
-glucuronidase activity is responsible for this deglucuronida-
tion, as certain members of the GM exhibit high -glucuron-
idase activity (19, 20). It has been shown that the capacity of
deglucuronidation can vary between individuals (19) and that it
can be altered by treatment with probiotics or a change in diet
(21, 35). Collectively, these findings demonstrate that the GM
in cecum is crucial for the substantial deglucuronidation of
DHT and T at this site in young and healthy mice.
The efficient deglucuronidation of DHT in cecum resulted in
free DHT levels in cecum and downstream in colon that were
considerably higher than serum DHT levels. Remarkably, in
female mice the levels of free DHT in the distal intestinal
content were higher than in any of the other tissues evaluated,
except for the liver. In contrast, GF mice without bacteria in
cecum had low levels of free DHT in the distal intestinal
content. To exclude the possibility that high levels of 5-
reductase activity in the distal intestinal wall contributed to the
observed high free DHT levels in the distal intestinal content of
mice with a normal GM, we analyzed Srd5a1–3 mRNA levels
in the intestinal wall. None of these transcripts was highly
expressed at this site, arguing against a substantial 5-reduc-
tase activity in the distal intestinal wall. However, we cannot
exclude the possibility that local conversion of T into DHT
partially contributed to the high free DHT levels in the distal
intestinal content. Similar to our findings in mice, levels of
unconjugated DHT in feces substantially exceeded the serum
DHT values in healthy young adult men, demonstrating that
not only mice but also humans have very high unconjugated
DHT levels in the distal intestinal content.
In contrast to free DHT, free T levels were not elevated in
cecum or colon of mice with normal GM, with free T levels in
the distal intestinal content that were similar to serum T levels.
Previous studies have shown that intestinal tissue can metab-
olize T into A-dione, DHT, and other metabolites (16, 17, 44).
This metabolic capacity could at least partly explain why the
extensive deglucuronidation of glucuronidated T did not result
in high free T levels in the cecal content. Furthermore, differ-
ences in the transportation of DHT and T via the portal vein or
via the intestinal lymphatic system to the systemic circulation
might contribute to the observed differences in the ratios
between the intestinal content and serum for DHT and T (40).
A-dione was present throughout the GI tract, but mainly in its
unconjugated form. This finding is most likely explained by the
fact that A-dione must be converted to androstanedione before
glucuronidation (7).
The finding of very high free DHT levels in the distal
intestinal content of mice with a normal GM composition and
men was unexpected, and the physiological and pathophysio-
logical roles of DHT within the distal intestine are mainly
unknown. DHT has been reported to increase smooth muscle
contractility in colon, an action dependent on the androgen
receptor (22, 23). Furthermore, androgens can influence intes-
tinal endothelial function (5). It is thus justified to hypothesize
that the high levels of DHT, being the most potent androgen,
could have a role in the regulation of the contractility and
permeability of the distal intestinal wall. Our novel finding of
high free DHT levels in the distal intestinal content of mice and
men may have implications also for the pathophysiology of
intestinal diseases. In humans, the age-adjusted incidence of
colon cancer is higher in men than in women (1, 18), and a
study in rats has shown that orchidectomy decreases the risk of
colonic adenomas and T treatment of orchiectomized rats
increases this risk (3). In addition, irritable bowel syndrome
(IBS) has been reported to be more common in women than in
men (31), and it has been suggested that androgens protect
against IBS (27). Furthermore, male patients with IBS show a
symptomatology different from that in women, with more men
reporting diarrhea whereas constipation is more common in
women (11, 36). One may speculate that pharmacological or
nutritional treatments affecting the GM composition may
change the free DHT levels in the distal intestine and thus have
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an impact on the risk and pathophysiology of intestinal dis-
eases having a link to androgens, such as colon cancer or IBS.
We also determined the androgen levels and androgenic
responses in serum and extraintestinal tissues of GF mice.
Using a gold standard MS-based method, we did not observe
any significant changes in serum T levels in 8-wk-old male GF
C57BL/6 mice compared with CONV-R mice. This is in
contrast with previous studies reporting decreased serum T
levels in male GF mice compared with mice with a normal GM
composition (33, 46, 49, 50). Also, several of these studies
indicated that the sexual dimorphism in serum T levels is
attenuated in GF mice (33, 49, 50). These studies used less
specific immunoassay-based techniques for analysis of serum
T levels, with known limitations in the lower concentration
range (26, 30), and different mouse strains, most probably with
different GM compositions, at different ages compared with
the present study. Interestingly, our study demonstrated ele-
vated tissue DHT levels in the liver and seminal vesicles of
male GF mice, with a similar trend in the thymus. These data
were accompanied by signs of enhanced androgen action in
seminal vesicles (increased seminal vesicle weight) and thy-
mus (reduced thymus weight) and an increase in serum FSH.
The increased FSH levels in GF mice could contribute to the
observed larger testis, as FSH regulates the number of Sertoli
cells during development (38). However, previous studies,
using GF mice on other genetic backgrounds (outbred strains
NMRI and JcI:ICR, respectively) and from other animal facil-
ities with most likely distinct GM compositions in the control
mice, did not detect any difference in testis weight between GF
mice and control mice (2, 42). FSH has been shown to regulate
5-reductase activity (39), and this might have contributed to
the increased tissue levels of DHT in liver and seminal vesicles
in GF mice in the present study. Thus our findings might
indicate that the GM has the capacity to modulate androgen
metabolism and action also at extraintestinal locations, but
further studies are required to clarify the mechanism.
Our study has strengths but naturally also limitations. Our
validated mass spectrometry-based detection method for anal-
DHT T
0
10,000
20,000
30,000
40,000
50,000
An
dr
og
en
(p
g/
g 
fe
ce
s,
 p
g/
m
l s
er
um
)
serum   feces serum   feces
*
Fig. 10. Comparison of unconjugated androgen levels in feces and serum of
young adult men. Unconjugated (free) dihydrotestosterone (DHT) and testos-
terone (T) levels were measured by gas chromatography-tandem mass spec-
trometry. Values are shown as means SE; n  8 subjects. *P  0.016
according to Student’s 2-tailed paired t test.
Table 4. Body and organ weights of conventionally raised and germ-free C57BL/6 mice
Male Female
Mean  SE % Difference Mean  SE % Difference
BW, g
CONV-R 23.0 0.5 NS 18.8  0.28 NS
GF 23.9  0.5 18.8  0.50
Liver, % of BW
CONV-R 4.87 0.14 –26%*** 4.81 0.11 –15%**
GF 3.58  0.05 4.10  0.19
Gonadal fat, % of BW
CONV-R 0.91 0.06 NS 0.51  0.03 –60%***
GF 0.88  0.05 0.20  0.02
Thymus, % of BW
CONV-R 0.19 0.008 –30%*** 0.27 0.01 NS
GF 0.13  0.007 0.25 0.01
Testes, % of BW
CONV-R 0.72 0.05 20%*
GF 0.87  0.03
Seminal vesicles, % of BW
CONV-R 0.58 0.03 14%*
GF 0.65  0.02
Values are shown as means  SE; n  10 mice per group. BW, body weight; CONV-R, conventionally raised; GF, germ free. Significance according to
Student’s unpaired 2-tailed t test denoted as nonsignificant (NS)  P  0.05, *P 	 0.05, **P 	 0.01, ***P 	 0.0001.
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Significance: *P 	 0.05 according to Student’s 2-tailed unpaired t test.
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yses of androgens in intestinal contents is both sensitive and
specific, avoiding misclassification of androgens. One limita-
tion with the GF mouse model is that it, for example, has an
underdeveloped immune system, and as the mice have been
lacking GM from birth we cannot exclude possible confound-
ing developmental effects (32). We did not analyze androgen
levels of small intestinal contents from GF mice.
In conclusion, the findings in the present study demonstrate
that the GM in the cecum deglucuronidates high levels of
glucuronidated DHT and T found in the small intestinal con-
tent. This results in remarkably high free levels of the potent
androgen DHT in the distal intestinal content of healthy young
mice of both sexes and men. We propose that treatments with
probiotics or changes in the diet affecting the GM composition
might modulate intestinal androgen metabolism and thereby
affect the risk of androgen-related diseases mainly in the distal
intestine, but potentially also at extraintestinal locations. Fur-
ther studies are needed to evaluate the physiological and
pathophysiological roles of the high levels of free DHT in the
distal intestine.
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